DD216043A5 - Verfahren zur herstellung eines plasmids - Google Patents

Verfahren zur herstellung eines plasmids Download PDF

Info

Publication number
DD216043A5
DD216043A5 DD83258476A DD25847683A DD216043A5 DD 216043 A5 DD216043 A5 DD 216043A5 DD 83258476 A DD83258476 A DD 83258476A DD 25847683 A DD25847683 A DD 25847683A DD 216043 A5 DD216043 A5 DD 216043A5
Authority
DD
German Democratic Republic
Prior art keywords
plasmid
sequence
dna
per
item
Prior art date
Application number
DD83258476A
Other languages
German (de)
English (en)
Inventor
Marc-Bruce Dworkin
Eva Dworkin-Rastl
Guenther Adolf
Norbert Hauel
Peter Meindl
Peter Swetly
Rudolf Hauptmann
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DD216043A5 publication Critical patent/DD216043A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DD83258476A 1982-12-24 1983-12-22 Verfahren zur herstellung eines plasmids DD216043A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823247922 DE3247922A1 (de) 1982-12-24 1982-12-24 Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten

Publications (1)

Publication Number Publication Date
DD216043A5 true DD216043A5 (de) 1984-11-28

Family

ID=6181687

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83258476A DD216043A5 (de) 1982-12-24 1983-12-22 Verfahren zur herstellung eines plasmids

Country Status (19)

Country Link
EP (1) EP0115613B1 (fi)
JP (2) JPH088868B2 (fi)
KR (1) KR930005455B1 (fi)
AT (1) ATE62018T1 (fi)
AU (1) AU579991B2 (fi)
DD (1) DD216043A5 (fi)
DE (2) DE3247922A1 (fi)
DK (1) DK576983A (fi)
ES (4) ES528350A0 (fi)
FI (1) FI86991C (fi)
GR (1) GR78766B (fi)
HU (1) HU202277B (fi)
IL (1) IL70523A (fi)
MX (1) MX9202878A (fi)
NO (1) NO173742C (fi)
NZ (1) NZ206700A (fi)
SU (2) SU1366064A3 (fi)
UA (1) UA8035A1 (fi)
ZA (1) ZA839519B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170204B1 (de) * 1984-08-01 1991-09-25 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Neue genetische Sequenzen, die durch sie codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
HU204563B (en) * 1984-12-06 1992-01-28 Synergen Biolog Inc Process for producing recombinant serine-protease inhibitors and dns sequencyes for them
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DK156072C (da) * 1985-04-03 1989-11-06 Nordisk Gentofte Syntetisk dna-sekvens indeholdende et ribosombindingssted
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
DE3514113A1 (de) * 1985-04-19 1986-10-23 Hoechst Ag, 6230 Frankfurt Veraenderung der dna-sequenz zwischen shine-dalgarno-sequenz und startcodon des trp-operons zur steigerung der proteinexpression
US4874703A (en) * 1985-08-26 1989-10-17 Eli Lilly And Company Expression vectors for use in E. coli
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
WO1990005186A1 (en) * 1988-11-04 1990-05-17 The Upjohn Company Somatotropin expression using a serratia promoter
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US5531880A (en) * 1994-09-13 1996-07-02 Microelectronics And Computer Technology Corporation Method for producing thin, uniform powder phosphor for display screens
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
ZA814375B (en) * 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
DE3247923A1 (de) * 1982-12-24 1984-06-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue oligonucleotide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS59162888A (ja) 1984-09-13
DE3247922A1 (de) 1984-06-28
ES8506090A1 (es) 1985-06-16
UA8035A1 (uk) 1995-12-26
FI86991B (fi) 1992-07-31
FI834700A0 (fi) 1983-12-21
ATE62018T1 (de) 1991-04-15
AU2283283A (en) 1984-06-28
ES8503372A1 (es) 1985-02-16
ES533197A0 (es) 1985-02-16
AU579991B2 (en) 1988-12-22
GR78766B (fi) 1984-10-02
SU1366064A3 (ru) 1988-01-07
NO173742B (no) 1993-10-18
KR930005455B1 (ko) 1993-06-22
ES8504930A1 (es) 1985-04-16
KR840007105A (ko) 1984-12-05
FI86991C (fi) 1992-11-10
ES8501798A1 (es) 1984-12-01
ES528350A0 (es) 1984-12-01
IL70523A (en) 1991-08-16
ES533213A0 (es) 1985-06-16
NZ206700A (en) 1987-11-27
HU202277B (en) 1991-02-28
ES533214A0 (es) 1985-04-16
DE3382233D1 (de) 1991-05-02
JPH05214000A (ja) 1993-08-24
SU1417800A3 (ru) 1988-08-15
FI834700A (fi) 1984-06-25
DK576983A (da) 1984-06-25
IL70523A0 (en) 1984-03-30
EP0115613B1 (de) 1991-03-27
DK576983D0 (da) 1983-12-14
ZA839519B (en) 1985-08-28
MX9202878A (es) 1992-06-30
EP0115613A2 (de) 1984-08-15
NO173742C (no) 1994-01-26
EP0115613A3 (en) 1986-07-23
JP2637328B2 (ja) 1997-08-06
NO834792L (no) 1984-06-25
JPH088868B2 (ja) 1996-01-31

Similar Documents

Publication Publication Date Title
EP0171024B1 (de) Gentechnologisches Verfahren zur Herstellung von Hirudinen und Mittel zur Durchführung dieses Verfahrens
EP0168342B1 (de) Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3111405C2 (fi)
DE3786767T3 (de) Neues Polypeptid.
EP0115613B1 (de) DNA-Sequenzen, deren Herstellung, diese Sequenzen enthaltende Plasmide und deren Verwendung zur Synthese eukaryotischer Genprodukte in Prokaryoten
DD210304A5 (de) Verfahren zur herstellung eines replikablen vektors
EP0161504B1 (de) Herstellung von Polypeptiden mit Human-Gammainterferon-Aktivität
DE2848051A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DE3686399T2 (de) Herstellung von thrombin-inhibitoren.
DE2848053A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DE2848052A1 (de) Synthetische dna und verfahren zu ihrer herstellung
DD209652A5 (de) Verfahren zur herstellung eines replikablen vektors
DD212748A5 (de) Verfahren zur bildung doppelstraengiger, hybride human-leukozyten-interferone kodierender dns
DD211359C4 (de) Verfahren zur herstellung eines mikroorganismus
DD212532A5 (de) Verfahren zur stabilisierung und selektion von wirtszellen, die rekombinierende dna enthalten
EP0211299A2 (de) Fusionsproteine, Verfahren zu ihrer Herstellung und ihre Verwendung
DD219212A5 (de) Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors
EP0163249B1 (de) Gentechnologisches Verfahren zur Herstellung von Human-Interleukin-2 und Mittel zur Durchführung dieses Verfahrens
DE3751100T2 (de) Erhöhte Produktion von Proteinen in Bakterien durch Verwendung einer neuen Ribosombindungsstelle.
EP0133282B1 (de) Herstellung von Polypeptiden mit einem Säureamid-Carboxyterminus
EP0146785B1 (de) Verfahren zur Herstellung von Protease-Inhibitoren
DE3751081T2 (de) [Leu 13] Motilin, dessen kodierende DNS-Moleküle und Verfahren zu dessen Herstellung.
EP0292763A2 (de) Gentechnologisches Verfahren zur Herstellung von Angiogeninen
DE3485923T2 (de) Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.
EP0173149B1 (de) Synthetische Regulationsregion